Portal del Investigador
Biodegradable and Eco-friendly Smart Hydrogels for the Sustained Intraperitoneal Release of Chemotherapeutics as a Novel Local Therapy Approach for Advanced Ovarian Cancer
Más información
| Fecha de publicación: | 2023 |
| Objetivos: | goal of HydroTheC is to provide a new injectable non-toxic Smart HG as a new delivery depo-system to significantly increase the standard-of-care therapeutic window and reduce the appearance of therapy resistance, thus increasing patient survival and welfare |
| Año de Inicio/Término: | 2023-2026 |
| Financiamiento/Sponsor: | HORIZON-TMA-MSCA-PF-GF |
| Rol del Usuario: | INVESTIGADOR(A) PATROCINANTE |
| Notas: | Ovarian Cancer (OC) is usually diagnosed in advanced stages when metastasis into the intra-abdominal (i.a.) cavity already occurred. The OC standard-of-care efficacy is hampered by drugs high systemic toxicity and the early appearance of resistance. Thus, advanced OC remains an unmet clinical need, |